Completion of new primary healthcare centre

RNS Number : 1269F
The MedicX Fund Limited
11 June 2012
 



 

 

For immediate release                                                                                       11 June 2012

 

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

 

Completion of new primary healthcare centre

 

 

MedicX Fund, (LSE: MXF), the specialist investor in modern, purpose built primary healthcare infrastructure properties in the United Kingdom, is pleased to announce that it has successfully completed the acquisition of a new medical centre at the Mary Seacole Centre in Clapham High Street, London SW4. The transaction was a forward purchase of the long leasehold interest, as previously announced.

 

The property is let to a GP practice on the basis of a 20 year lease which is subject to effective upward only rent reviews to market rent every 3 years.

 

The total acquisition cost of the property was £6.9 million and the asset will contribute £0.4 million to the annualised rent roll of the portfolio.

 

The MedicX Fund's total property portfolio comprises 73 properties throughout the United Kingdom of which 63 are complete and 10 are under construction. The annualised rent roll for all properties is £18.3 million.

End

 

 

For further information please contact:

 

 

MedicX Group

+44 (0) 1483 869 500

Keith Maddin, Chairman

 

Mike Adams, Chief Executive Officer

 

Mark Osmond, Chief Financial Officer

 

 

 

MedicX Fund

+44 (0) 1481 723 450

David Staples, Chairman

 

 

 

Buchanan   

+44 (0) 20 7466 5000

Charles Ryland/Suzanne Brocks

 

 

 

 

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 73 properties.

 

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.

 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKDDDPBKDDAD
UK 100

Latest directors dealings